Mare Nostrum Logo

Mare Nostrum

Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.

ALMAR | PA

Overview

Corporate Details

ISIN(s):
FR0013400835
LEI:
9695001D0TLYAWZSX187
Country:
France
Address:
9 AVENUE DE CONSTANTINE, 38100 GRENOBLE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Groupe Mare Nostrum is a human resources engineering company with over 20 years of experience. The group specializes in a comprehensive range of HR solutions, including recruitment, temporary work, professional training, and wage portage (umbrella company services). Comprising over 190 employees, the company operates through 18 dedicated brands across five core areas of expertise. Groupe Mare Nostrum's strength lies in the complementarity of its businesses and services, enabling it to offer integrated and tailored HR support to its clients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-05 18:45
Legal Proceedings Report
MARE NOSTRUM : Nouvelle étape franchie - Approbation des plans de redressement …
French 282.1 KB
2025-07-21 18:30
Legal Proceedings Report
MARE NOSTRUM : Approbation du plan de continuation par le Tribunal de Commerce …
French 287.9 KB
2025-06-30 18:45
Legal Proceedings Report
MARE NOSTRUM : Approbation du projet de plan de continuation par les créanciers
French 308.8 KB
2025-06-18 18:00
Business and Financial Review
MARE NOSTRUM dévoile sa nouvelle politique de marques
French 346.4 KB
2025-06-16 19:15
Pre-Annual General Meeting Information
MARE NOSTRUM : Assemblée Générale Mixte du 30 juin 2025 - Mise à disposition d…
French 254.0 KB
2025-05-30 07:30
Legal Proceedings Report
MARE NOSTRUM : Projet de plan de continuation finalisé - Mise à disposition aup…
French 310.7 KB
2025-05-22 18:30
Earnings Release
MARE NOSTRUM : Chiffre d’affaires solide au 1er trimestre 2025 de 28 MEUR - Fin…
French 313.2 KB
2025-05-15 18:06
Earnings Release
MARE NOSTRUM : Résultats annuels 2024 - Amélioration des performances opération…
French 299.0 KB
2025-04-28 20:00
Report Publication Announcement
MARE NOSTRUM : Report de publication des résultats annuels et du Rapport financ…
French 264.4 KB
2025-01-22 18:00
Legal Proceedings Report
MARE NOSTRUM : Point d’étape sur la procédure - Prolongation exceptionnelle de …
French 265.6 KB
2025-01-14 18:00
Transaction in Own Shares
MARE NOSTRUM : Bilan du contrat de liquidité au 31 décembre 2024
French 281.5 KB
2025-01-06 18:30
Board/Management Information
MARE NOSTRUM : Renforcement de la division Travail Temporaire - Nomination d’un…
French 287.3 KB
2024-12-20 18:00
Legal Proceedings Report
MARE NOSTRUM : Point d’étape sur la procédure et entrée en discussion avec Domi…
French 295.9 KB
2024-12-12 18:00
Regulatory News Service
MARE NOSTRUM : Celtic Travail Temporaire reconnue PME Excellence 2023 au Portug…
French 331.3 KB
2024-10-31 18:37
Earnings Release
Mare Nostrum : Résultats semestriels 2024 - Poursuite de la réorganisation et …
French 370.1 KB

Automate Your Workflow. Get a real-time feed of all Mare Nostrum filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mare Nostrum via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.